Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

doi:10.1186/1744-859X-8-15

Annals of General Psychiatry

Volume 8

Viewing options:

Abstract
Full text
PDF (169KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Geitona M
Kousoulakou H
Ollandezos M
Athanasakis K
Papanicolaou S
Kyriopoulos I

on PubMed

Geitona M
Kousoulakou H
Ollandezos M
Athanasakis K
Papanicolaou S
Kyriopoulos I
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Correction

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

Maria Geitona¹ , Hara Kousoulakou² , Markos Ollandezos³ , Kostas Athanasakis³ , Sotiria Papanicolaou⁴ and Ioannis Kyriopoulos³

¹Department of Economics, University of Thessaly, Magnissias 96, Dionyssos 14576, Greece

²Institute for Economic and Industrial Research, Tsami Karatasi 11, 117 42 Athens, Greece

³Department of Health Economics, National School of Public Health, Aleksandra's Avenue 196, 11521 Athens, Greece

⁴Janssen-Cilag Pharmaceutical SACI, Eirinis Avenue 56, 15121 Pefki, Athens, Greece

author email corresponding author email

Annals of General Psychiatry 2009, 8:15doi:10.1186/1744-859X-8-15


Published:	18 June 2009

Abstract

Correction to Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S and Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Annals of General Psychiatry 2008, 7:16. This correction reports changes in the values listed for Ziprasidone and Aripiprazole in Table Ten.